Blood-Based Biomarkers Predictive of Metformin Target Engagement in Fragile X Syndrome

Recent advances in neurobiology have provided several molecular entrees for targeted treatments for Fragile X syndrome (FXS). However, the efficacy of these treatments has been demonstrated mainly in animal models and has not been consistently predictive of targeted drugs’ response in the prepondera...

Descripción completa

Detalles Bibliográficos
Autores principales: Jasoliya, Mittal, Bowling, Heather, Petrasic, Ignacio Cortina, Durbin-Johnson, Blythe, Klann, Eric, Bhattacharya, Aditi, Hagerman, Randi, Tassone, Flora
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349631/
https://www.ncbi.nlm.nih.gov/pubmed/32531912
http://dx.doi.org/10.3390/brainsci10060361

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349631/
https://www.ncbi.nlm.nih.gov/pubmed/32531912
http://dx.doi.org/10.3390/brainsci10060361

Ejemplares similares